Background
==========

Nephrolithiasis is the clinical term used for the formation of stones in the renal pelvis and ureter. Intermittent renal colic and hematuria are the main clinical symptoms of nephrolithiasis, which can lead to chronic kidney disease and loss of renal function. In the adult population in China, between 2013 and 2014, the prevalence of nephrolithiasis was 5.8%, and the estimated number of patients with nephrolithiasis was 1.1 billion \[[@b1-medscimonit-26-e919360]\]. Nephrolithiasis has a high recurrence rate of between 6.12% and 34.17% at one year and five years, respectively \[[@b2-medscimonit-26-e919360]\].

Developments in the clinical management of kidney stones have resulted in the development of extracorporeal shock wave lithotripsy, which is now the first-line approach to the treatment of nephrolithiasis. However, lithotripsy is expensive and is followed by a high recurrence rate of kidney stones in approximately 50% of cases at between 5--10 years, which increases to 75% in 20 years \[[@b3-medscimonit-26-e919360]\]. Therefore, approaches to the prevention of the formation of kidney stones are required. Chinese herbal medicine has a long history of nephrolithiasis treatment, even before Western medicine. Chinese herbal medicine, such as takusya, jin qian cao, desmodyum styracyfolium, and wulingsan, can increase the excretion of urinary citrate, reduce urinary calcium and oxalic acid excretion, and have diuretic effects, that can prevent nephrolithiasis \[[@b4-medscimonit-26-e919360]\].

Christina Loosestrife, or *Lysimachia Christinae* (Jin Qian Cao), is a traditional Chinese medicine used in the treatment of nephrolithiasis \[[@b5-medscimonit-26-e919360],[@b6-medscimonit-26-e919360]\]. A flavonoid extract of Christina Loosestrife has been shown to inhibit the formation of calcium oxalate crystals in a rat model of hyperoxaluria by interfering with calcium metabolism \[[@b7-medscimonit-26-e919360]\]. The total flavonoid content of Christina Loosestrife increased in the urine of rats, and an increase in urinary prothrombin fragment 1 (UPTF1) was associated with reduced urinary calcium and uric acid \[[@b8-medscimonit-26-e919360]\]. Christina Loosestrife has an inhibitory effect on the formation of calcium oxalate crystals in human urine \[[@b9-medscimonit-26-e919360]\]. It can be used in patients with urinary calculi after extracorporeal shock wave lithotripsy and has been shown to reduce the recurrence rate of urinary calculi \[[@b10-medscimonit-26-e919360]\]. However, the pharmacological mechanisms of Christina Loosestrife remain unknown.

Therefore, this study aimed to undertake a network pharmacology analysis to identify the active compounds of the herbal extract Christina Loosestrife, or *Lysimachia Christinae* (Jin Qian Cao), in the treatment of nephrolithiasis.

Material and Methods
====================

Screening for the effective chemical components of Christina Loosestrife
------------------------------------------------------------------------

The active components of Christina Loosestrife, or *Lysimachia Christinae* (Jin Qian Cao), were identified from the Traditional Chinese Medicine Systems Pharmacology (TCMSP) database and analysis platform (*<http://ibts.hkbu.edu.hk/LSP/tcmsp.php>*) \[[@b11-medscimonit-26-e919360]\], and the online Taiwan TCM database (*<http://tcm.cmu.edu.tw/>*) \[[@b12-medscimonit-26-e919360]\]. The chemical components were identified using search keywords that included Jin Qian Cao. Lian Qian Cao, and Christina Loosestrife, using PubMed, CNKI, and the Wanfang databases. Because the flavone glycoside may be hydrolyzed to glycosides in the gut by intestinal enzymes, both flavonoid glycosides and glycosides were identified.

The molecular structure of the compounds was confirmed using the PubChem or ChemSpider chemical structure database platforms. Based on the absorption, distribution, metabolism, excretion, and toxicity (ADME/T) value calculated by the TCMSP database, compounds with an oral bioavailability (OB) \<30%, a drug-like index (DL) \<0.18, or low concentration were omitted. Compounds with an OB ≥30% and a DL ≥0.18 were selected as active compounds for further investigation, and their structural diagrams obtained from the database were stored in two formats, the MOL and SDF formats. These two-dimensional (2D) structures of the components were converted to three-dimensional (3D) structure diagrams using ChemDraw Professional version 16.0 software (PerkinElmer, Waltham, MA, USA), and saved as MOL2 format files.

Reverse target prediction
-------------------------

The main active ingredients of the Christina Loosestrife were uploaded to the PharmMapper server (*<http://59.78.98.102/pharmmapper/>*) \[[@b13-medscimonit-26-e919360]--[@b15-medscimonit-26-e919360]\] in MOL2 format. The search term, Human Protein Targets Only for Select Targets Set was the default setting for the remaining parameters. The Protein Data Bank identity (PDB ID) of the filtered protein target was imported into the UniProt (*<https://www.uniprot.org/>*) database, and the prediction targets of the active ingredients of Christina Loosestrife were obtained by retrieval and transformation.

Screening of nephrolithiasis-associated targets
-----------------------------------------------

The keywords, kidney stone or nephrolithiasis were used to search the Online Mendelian Inheritance in Man (OMIM) database \[[@b16-medscimonit-26-e919360]\] (*<http://omim.org/>*), the MalaCards integrated annotation database \[[@b17-medscimonit-26-e919360]\], and PubMed, to obtain the reported genes associated with nephrolithiasis. After removing repetitive genes and false-positive genes, nephrolithiasis-associated targets were collected.

Molecular docking and binding affinity
--------------------------------------

Molecular docking is often used to study the interaction between active small molecules with key network targets \[[@b18-medscimonit-26-e919360],[@b19-medscimonit-26-e919360]\]. The active compound (MOL2 format) and the target protein PDB ID were uploaded to the systemsDock version 2.0 network pharmacology website (*<http://systemsdock.unit.oist.jp>*), an online molecular docking program \[[@b20-medscimonit-26-e919360]\]. The smaller the binding free energy, the more stable the ligand-receptor binding, and the larger the docking score, the more stable the ligand-receptor binding. A docking score \>4.25 indicated binding affinity between the molecule and the target. A docking score \>5.0 indicated that the molecule had a good binding affinity to the target. A docking score \>7.0 indicated a strong binding affinity \[[@b21-medscimonit-26-e919360]\]. The binding affinity between the core target and the active compound was evaluated based on the proportion of the active compound with a docking score of ≥4.25, which verified the validity of the potential core target.

Biological functions and pathway outcomes analysis of the targets
-----------------------------------------------------------------

Biological functions and pathway outcomes of effective targets were analyzed using the Metascape gene annotation platform (*<http://metascape.org/>*) \[[@b22-medscimonit-26-e919360]\], in which the input as species and the analysis as species were selected as H. sapiens, and the threshold was set as P\<0.01. Gene Ontology (GO) annotation and Reactome signaling pathway analysis were performed. The results were sorted according to the number of targets involved in each pathway, and the top biological processes and signaling pathways were selected and visualized using GraphPad Prism version 7.0 software (GraphPad Software, La Jolla, CA, USA).

Network construction
--------------------

The compound-target network and target-pathway network were constructed and merged into the compound-target-pathway network using Cytoscape version 3.6.1 (*<https://cytoscape.org/>*) to achieve a systematic understanding of the complex relationships among compounds, targets, and nephrolithiasis \[[@b23-medscimonit-26-e919360]\].

Results
=======

Screening for the effective chemical components of Christina Loosestrife and target prediction
----------------------------------------------------------------------------------------------

A total of 188 compounds were identified for Christina Loosestrife from the Traditional Chinese Medicine Systems Pharmacology (TCMSP) database, the online Taiwan TCM database, and the literature search. Following the absorption, distribution, metabolism, excretion, and toxicity (ADME/T) calculation, 16 compounds with an oral bioavailability (OB) ≥30%, and a drug-like index (DL) ≥0.18 were identified as effective active compounds ([Figure 1](#f1-medscimonit-26-e919360){ref-type="fig"}, [Table 1](#t1-medscimonit-26-e919360){ref-type="table"}). These chemical compounds were searched using the PharmMapper integrated pharmacophore matching platform for reverse prediction, and 414 targets were obtained. There were 155 nephrolithiasis-associated targets identified after screening using the Online Mendelian Inheritance in Man (OMIM), the MalaCards integrated annotation database and the PubMed database. There were 11 common targets for Christina Loosestrife and nephrolithiasis ([Table 1](#t1-medscimonit-26-e919360){ref-type="table"}).

Molecular docking
-----------------

Docking of the 16 active compounds and 11 targets was simulated using systemsDock, with the default parameters. The docking scores of the candidate compounds are shown in [Table 2](#t2-medscimonit-26-e919360){ref-type="table"}. The molecular docking results identified 13 (81.3%) active compounds associated with JAK2 (PDBID: 3UGC), which had a docking score \>4.25. There were 10 (62.5%) active compounds associated with BIRC7 (PDBID: 2I3H), with a docking score of \>4.25. There were 8 (50%) active compounds associated with F2 (PDBID: 4UD9), with a docking score of \>4.25. There were 10 (62.5%) active compounds with MMP9 (PDBID: 6ESM), with a docking score of \>4.25. There were 9 (56.3%) active compounds with VDR (PDBID: 3B0T), with a docking score of \>4.25. There were 8 (50.0%) active compounds with GBA (PDBID: 2NT0), with a docking score of \>4.25. There were 11 (68.8%) active compounds with APRT (PDBID: 4X45), with a docking score of \>4.25. There were 11 (68.8%) active compounds with HPRT1 (PDBID: 4RAO), with a docking score of \>4.25. There were12 active compounds (75.0%) with AGXT (PDBID: 5F9S), with a docking score of \>4.25. There were 8 (50.0%) active components with LCN2 (PDBID: 4MVK), with a docking score of \>4.25. Due to the lack of a crystal structure, molecular docking was not performed on REG1A. The molecular docking results showed that most of the active constituents of Christina Loosestrife had good binding ability to the key targets in the network.

The analysis of the target biological functions and pathways of Christina Loosestrife
-------------------------------------------------------------------------------------

Gene Ontology (GO) functional enrichment analysis and pathway functional analysis were performed for the 11 effective targets that were identified by molecular docking. For biological process, terms such as adenine salvage, regulation of body fluid levels, and cellular response to oxidative stress were enriched ([Figure 2A](#f2-medscimonit-26-e919360){ref-type="fig"}). For the cellular component, the terms including secretory granule lumen, cytoplasmic vesicle lumen, and vesicle lumen were enriched ([Figure 2B](#f2-medscimonit-26-e919360){ref-type="fig"}). Terms that included purine phosphoribosyltransferase activity, cofactor binding, and serine-type endopeptidase activity were enriched for molecular function ([Figure 2C](#f2-medscimonit-26-e919360){ref-type="fig"}). The reaction pathway analysis showed that most targets were enriched in neutrophil degranulation, interleukin-4 (IL-4) and IL-13 signaling, and purine salvage ([Figure 2D](#f2-medscimonit-26-e919360){ref-type="fig"}).

Network construction and analysis
---------------------------------

Based on the above findings, the nephrolithiasis-associated compound-target-pathway network of Christina Loosestrife was validated. The effective target proteins, chemical constituents, and pathways were imported into Cytoscape software to construct the compound-target component ([Figure 3](#f3-medscimonit-26-e919360){ref-type="fig"}), target-pathway ([Figure 4](#f4-medscimonit-26-e919360){ref-type="fig"}) and compound-target-pathway network diagrams ([Figure 5](#f5-medscimonit-26-e919360){ref-type="fig"}). Targets and compounds with high node degrees are shown in [Table 3](#t3-medscimonit-26-e919360){ref-type="table"}. In the compound-target network, there were 154 sides and 27 nodes. In the target-pathway network, there were 17 sides and 12 nodes. In the compound-target-pathway network, there were 171 sides and 34 nodes. These results indicated the complex relationship between compounds, targets, and pathways of Christina Loosestrife in nephrolithiasis.

Discussion
==========

The present study aimed to investigate the active compounds of the herbal extract Christina Loosestrife, or *Lysimachia Christinae* (Jin Qian Cao), in the treatment of nephrolithiasis using network pharmacology. Several pathways were identified, including neutrophil degranulation, interleukin-4 (IL-4), and IL-13 signaling, and purine recovery.

The glycoside, Eucommin A is the main lignan component of *Eucommia ulmoides*. Eucommin A has significant effects against free radical effects *in vivo* and *in vitro*, but there is no direct evidence to support a relationship between Eucommia A and antioxidant activity \[[@b24-medscimonit-26-e919360]\]. Hesperetin is a natural flavanon-glycoside derived from the citrus fruits of the Rutaceae family. Hesperetin can scavenge 2,2-diphenylpicrylhydrazyl (DPPH) free radicals and hydroxyl radicals \[[@b25-medscimonit-26-e919360]\]. Also, medioresinol is a furofuran type lignan that has strong antioxidant activity \[[@b26-medscimonit-26-e919360]\]. Flavonoids that include nepicatechin, luteolin, naringenin, quercetin, chrysoeriol, isorhamnetin, and kaempferol had a high degree of molecular docking, indicating that flavonoids are the main active compounds associated with the effects of Christina Loosestrife. This finding is supported by those from a previous study \[[@b27-medscimonit-26-e919360]\].

Among the flavonoids present in Christina Loosestrife, quercetin has effects in reducing oxidation and uric acid levels and has anti-inflammatory and diuretic effects \[[@b28-medscimonit-26-e919360]\]. Quercetin can also reduce kidney damage by increasing the activity of superoxide dismutase (SOD) and catalase. The antioxidant and anti-inflammatory effects of quercetin are associated with increased serum levels of paraoxonase/arylesterase 1 (PON1), and its effects on renal calculus formation may be associated with the inhibition of deposition of calcium oxalate crystals \[[@b29-medscimonit-26-e919360],[@b30-medscimonit-26-e919360]\]. Catechin is another important antioxidant found in plants, including tea and grapeseed \[[@b31-medscimonit-26-e919360]\]. Catechin may exert its antioxidant activity by removing free radicals and by metal chelation and regulating transcription factors and enzymes \[[@b32-medscimonit-26-e919360]\]. Catechin has previously been shown to regulate the expression of osteopontin (OPN), malondialdehyde (MDA), and 8-hydroxy-2′-deoxyguanosine (8-OHdG) in a rat model of nephrolithiasis \[[@b33-medscimonit-26-e919360]\]. Catechin also increased the activity of SOD activity in NRK-52E renal tubular epithelial cells treated with calcium oxalate *in vitro* to restore mitochondrial membrane potentials and degrade caspase-3 \[[@b33-medscimonit-26-e919360]\].

In the present study, several targets were identified that showed a high degree of molecular docking, including the tyrosine-protein kinase Janus kinase 2 (JAK2) (degree, 16), the 67 kDa matrix metalloproteinase-9 (MMP9) (degree, 15), adenine phosphoribosyltransferase (APRT) (degree, 14), hypoxanthine phosphoribosyl-transferase 1 (HPRT1) (degree, 13), alanine-glyoxylate and serine-pyruvate aminotransferase (AGXT) (degree, 12), and lipocalin-2 (LCN2) (degree, 9). These findings supported the roles of these compounds in the compound-target interactions. Previous studies have shown that the AGXT gene, which encodes alanine/glyoxylate aminotransferase, transfers glyoxylic acid to glycine in the liver, and deficiency leads to calcium oxalate deposits in multiple tissues \[[@b34-medscimonit-26-e919360],[@b35-medscimonit-26-e919360]\]. HPRT and APRT are key enzymes in the purine and pyrimidine nucleotide salvage pathway \[[@b36-medscimonit-26-e919360]\]. HPRT and APRT catalyze the salvage of the adenine and guanine into their respective monophosphate nucleosides, resulting in increased serum levels of uric acid \[[@b37-medscimonit-26-e919360]\]. LCN2, MMP9, and JAK2 are mainly involved in the regulation of oxidative stress and the immune response \[[@b37-medscimonit-26-e919360]--[@b40-medscimonit-26-e919360]\].

In the present study, Gene Ontology (GO) functional enrichment analysis identified several terms, including adenine salvage, the regulation of body fluid levels, and the cellular response to oxidative stress. Further pathway analysis showed that most targets were enriched in IL-4 and IL-13 signaling, purine salvage, and neutrophil degranulation. These findings are supported by those from a previous study that showed increased urinary uric acid levels were associated with the formation of urinary calculi in a rat model \[[@b41-medscimonit-26-e919360]\]. Hyperoxaluria plays an important role in promoting supersaturation of calcium oxalate calculi and is one of the three main factors in the formation of uric acid calculi \[[@b42-medscimonit-26-e919360]\]. Christina Loosestrife was shown in this study to have a possible role in reducing hyperoxaluria by regulating key factors, including hypoxanthine-guanine phosphoribosyltransferase (HPRT) and adenine phosphoribosyltransferase (APRT) in the purine salvage pathway. The inflammatory networks formed by these factors are important regulators for the formation of nephrolithiasis \[[@b43-medscimonit-26-e919360]\]. Exposure of epithelial cells to high concentrations of oxalic acid and calcium oxalate crystals can induce high levels of reactive oxygen species (ROS) and reduce the activity of superoxide dismutase (SOD) \[[@b44-medscimonit-26-e919360]\], and lead to cell apoptosis or necrosis \[[@b45-medscimonit-26-e919360]\]. Excessive ROS can induce renal epithelial cells to produce a series of cytokines, triggering an inflammatory response \[[@b46-medscimonit-26-e919360]\]. The findings from these previous studies support the findings from the present study hat Christina Loosestrife may reduce the inflammatory responses induced by oxalic acid and calcium oxalate crystals through the JAK2, LCN2, and MMP9 and inflammatory and immune-related pathways.

This study had several limitations. This network pharmacology study relied on data available from databases that included the Traditional Chinese Medicine Systems Pharmacology (TCMSP) database and analysis platform and the online Taiwan TCM database, which may not have included sufficient data. This study focused on the composition of the compounds identified. However, the study did not investigate the effects of the concentrations of these compounds, the interactions between them, and the *in vivo* metabolic processes involved. Therefore, this network pharmacology analysis of the herbal extract, Christina Loosestrife, may have included bias in the identification of active compounds, targets, and pathways involved in the effects on nephrolithiasis, or may have missed some of the compounds involved. Future functional studies should be undertaken to validate the findings from this network pharmacology study.

Conclusions
===========

This study aimed to undertake a network pharmacology study to identify the active compounds of the herbal extract Christina Loosestrife, or Lysimachia Christinae (Jin Qian Cao), in the treatment of nephrolithiasis. This study identified 16 active compounds of Christina Loosestrife and 11 nephrolithiasis-associated targets, which were enriched in several processes and pathways, including flavonoids and their glycosides, which are involved in purine metabolism and oxidative stress pathways.
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![The structure of the 16 active compounds in Christina Loosestrife.](medscimonit-26-e919360-g001){#f1-medscimonit-26-e919360}

![Enrichment analysis of potential targets of the active compounds of Christina Loosestrife in nephrolithiasis. Analysis of the Gene Ontology (GO) terms for biological process (**A**), cellular component (**B**), and molecular function (**C**), or analysis of the Reactome pathways (**D**) are shown. LogP is the log-value of the P-value. P\<0.05 is considered to be significant. To show the results more intuitively, the results of the enrichment analysis are shown by LogP. The count represents the number of genes.](medscimonit-26-e919360-g002){#f2-medscimonit-26-e919360}

![The compound target network associated with Christina Loosestrife in nephrolithiasis. The square represents the component; the circle represents the target; the size of the node represents the size of the node degree.](medscimonit-26-e919360-g003){#f3-medscimonit-26-e919360}

![The compound target network associated with Christina Loosestrife in nephrolithiasis. The circle represents the target; the octagon represents the tumor-related pathway; the size of the node represents the size of the node degree.](medscimonit-26-e919360-g004){#f4-medscimonit-26-e919360}

![The compound target network associated with Christina Loosestrife in nephrolithiasis. The square represents the component; the circle represents the target; the octagon represents the tumor-related pathway; the size of the node represents the size of its node degree.](medscimonit-26-e919360-g005){#f5-medscimonit-26-e919360}

###### 

The main active ingredients and protein targets in Christina Loosestrife.

  Compound                          Pubchem CID   OB (%)                                           DL     Gene    Uniprot ID   Target
  --------------------------------- ------------- ------------------------------------------------ ------ ------- ------------ ---------------------------------------------
  Quercetin                         5280343       46.43                                            0.28   AGXT    P21549       Serine pyruvate aminotransferase
  APRT                              P07741        Adenine phosphoribosyltransferase                                            
  BIRC7                             Q96CA5        Baculoviral IAP repeat-containing protein 7                                  
  F2                                P00734        Prothrombin                                                                  
  GBA                               P04062        Beta-glucocerebrosidase                                                      
  HPRT1                             P00492        Hypoxanthine-guanine phosphoribosyltransferase                               
  JAK2                              O60674        Tyrosine-protein kinase JAK2                                                 
  LCN2                              P80188        Neutrophil gelatinase-associated lipocalin                                   
  MMP9                              P14780        67 kDa matrix metalloproteinase-9                                            
  REG1A                             P05451        Lithostathine-1-alpha                                                        
  VDR                               P11473        Vitamin D3 receptor                                                          
  Epicatechin                       182232        48.96                                            0.24   AGXT    P21549       Serine pyruvate aminotransferase
  APRT                              P07741        Adenine phosphoribosyltransferase                                            
  BIRC7                             Q96CA5        Baculoviral IAP repeat-containing protein 7                                  
  F2                                P00734        Prothrombin                                                                  
  GBA                               P04062        Beta-glucocerebrosidase                                                      
  HPRT1                             P00492        Hypoxanthine-guanine phosphoribosyltransferase                               
  JAK2                              O60674        Tyrosine-protein kinase JAK2                                                 
  LCN2                              P80188        Neutrophil gelatinase-associated lipocalin                                   
  MMP9                              P14780        67 kDa matrix metalloproteinase-9                                            
  REG1A                             P05451        Lithostathine-1-alpha                                                        
  VDR                               P11473        Vitamin D3 receptor                                                          
  Hesperetin                        72281         70.31                                            0.27   AGXT    P21549       Serine\--pyruvate aminotransferase
  APRT                              P07741        Adenine phosphoribosyltransferase                                            
  BIRC7                             Q96CA5        Baculoviral IAP repeat-containing protein 7                                  
  F2                                P00734        Prothrombin                                                                  
  GBA                               P04062        Beta-glucocerebrosidase                                                      
  HPRT1                             P00492        Hypoxanthine-guanine phosphoribosyltransferase                               
  JAK2                              O60674        Tyrosine-protein kinase JAK2                                                 
  LCN2                              P80188        Neutrophil gelatinase-associated lipocalin                                   
  MMP9                              P14780        67 kDa matrix metalloproteinase-9                                            
  REG1A                             P05451        Lithostathine-1-alpha                                                        
  VDR                               P11473        Vitamin D3 receptor                                                          
  Naringenin                        932           59.29                                            0.21   AGXT    P21549       Serine pyruvate aminotransferase
  APRT                              P07741        Adenine phosphoribosyltransferase                                            
  BIRC7                             Q96CA5        Baculoviral IAP repeat-containing protein 7                                  
  F2                                P00734        Prothrombin                                                                  
  GBA                               P04062        Beta-glucocerebrosidase                                                      
  HPRT1                             P00492        Hypoxanthine-guanine phosphoribosyltransferase                               
  JAK2                              O60674        Tyrosine-protein kinase JAK2                                                 
  LCN2                              P80188        Neutrophil gelatinase-associated lipocalin                                   
  MMP9                              P14780        67 kDa matrix metalloproteinase-9                                            
  REG1A                             P05451        Lithostathine-1-alpha                                                        
  VDR                               P11473        Vitamin D3 receptor                                                          
  Luteolin                          5280445       36.16                                            0.25   AGXT    P21549       Serine\--pyruvate aminotransferase
  APRT                              P07741        Adenine phosphoribosyltransferase                                            
  BIRC7                             Q96CA5        Baculoviral IAP repeat-containing protein 7                                  
  F2                                P00734        Prothrombin                                                                  
  GBA                               P04062        Beta-glucocerebrosidase                                                      
  HPRT1                             P00492        Hypoxanthine-guanine phosphoribosyltransferase                               
  JAK2                              O60674        Tyrosine-protein kinase JAK2                                                 
  LCN2                              P80188        Neutrophil gelatinase-associated lipocalin                                   
  MMP9                              P14780        67 kDa matrix metalloproteinase-9                                            
  REG1A                             P05451        Lithostathine-1-alpha                                                        
  VDR                               P11473        Vitamin D3 receptor                                                          
  Medioresinol                      181681        87.19                                            0.62   AGXT    P21549       Serine pyruvate aminotransferase
  APRT                              P07741        Adenine phosphoribosyltransferase                                            
  BIRC7                             Q96CA5        Baculoviral IAP repeat-containing protein 7                                  
  F2                                P00734        Prothrombin                                                                  
  GBA                               P04062        Beta-glucocerebrosidase                                                      
  HPRT1                             P00492        Hypoxanthine-guanine phosphoribosyltransferase                               
  JAK2                              O60674        Tyrosine-protein kinase JAK2                                                 
  LCN2                              P80188        Neutrophil gelatinase-associated lipocalin                                   
  MMP9                              P14780        67 kDa matrix metalloproteinase-9                                            
  REG1A                             P05451        Lithostathine-1-alpha                                                        
  VDR                               P11473        Vitamin D3 receptor                                                          
  Kaempferol                        5280863       41.88                                            0.24   AGXT    P21549       Serine pyruvate aminotransferase
  APRT                              P07741        Adenine phosphoribosyltransferase                                            
  BIRC7                             Q96CA5        Baculoviral IAP repeat-containing protein 7                                  
  F2                                P00734        Prothrombin                                                                  
  GBA                               P04062        Beta-glucocerebrosidase                                                      
  HPRT1                             P00492        Hypoxanthine-guanine phosphoribosyltransferase                               
  JAK2                              O60674        Tyrosine-protein kinase JAK2                                                 
  MMP9                              P14780        67 kDa matrix metalloproteinase-9                                            
  REG1A                             P05451        Lithostathine-1-alpha                                                        
  VDR                               P11473        Vitamin D3 receptor                                                          
  Eucommin A                        442836        30.51                                            0.85   AGXT    P21549       Serine-pyruvate aminotransferase
  APRT                              P07741        Adenine phosphoribosyltransferase                                            
  BIRC7                             Q96CA5        Baculoviral IAP repeat-containing protein 7                                  
  F2                                P00734        Prothrombin                                                                  
  GBA                               P04062        Beta-glucocerebrosidase                                                      
  JAK2                              O60674        Tyrosine-protein kinase JAK2                                                 
  LCN2                              P80188        Neutrophil gelatinase-associated lipocalin                                   
  MMP9                              P14780        67 kDa matrix metalloproteinase-9                                            
  REG1A                             P05451        Lithostathine-1-alpha                                                        
  VDR                               P11473        Vitamin D3 receptor                                                          
  Isorha-mnetin                     5281654       49.6                                             0.31   AGXT    P21549       Serine pyruvate aminotransferase
  APRT                              P07741        Adenine phosphoribosyltransferase                                            
  BIRC7                             Q96CA5        Baculoviral IAP repeat-containing protein 7                                  
  F2                                P00734        Prothrombin                                                                  
  GBA                               P04062        Beta-glucocerebrosidase                                                      
  HPRT1                             P00492        Hypoxanthine-guanine phosphoribosyltransferase                               
  JAK2                              O60674        Tyrosine-protein kinase JAK2                                                 
  MMP9                              P14780        67 kDa matrix metalloproteinase-9                                            
  REG1A                             P05451        Lithostathine-1-alpha                                                        
  VDR                               P11473        Vitamin D3 receptor                                                          
  Acacetin                          5280442       34.97                                            0.24   APRT    P07741       Adenine phosphoribosyltransferase
  BIRC7                             Q96CA5        Baculoviral IAP repeat-containing protein 7                                  
  F2                                P00734        Prothrombin                                                                  
  GBA                               P04062        Beta-glucocerebrosidase                                                      
  HPRT1                             P00492        Hypoxanthine-guanine phosphoribosyltransferase                               
  JAK2                              O60674        Tyrosine-protein kinase JAK2                                                 
  LCN2                              P80188        Neutrophil gelatinase-associated lipocalin                                   
  MMP9                              P14780        67 kDa matrix metalloproteinase-9                                            
  REG1A                             P05451        Lithostathine-1-alpha                                                        
  VDR                               P11473        Vitamin D3 receptor                                                          
  Chrysoeriol                       5280666       35.85                                            0.27   AGXT    P21549       Serine\--pyruvate aminotransferase
  APRT                              P07741        Adenine phosphoribosyltransferase                                            
  BIRC7                             Q96CA5        Baculoviral IAP repeat-containing protein 7                                  
  F2                                P00734        Prothrombin                                                                  
  GBA                               P04062        Beta-glucocerebrosidase                                                      
  HPRT1                             P00492        Hypoxanthine-guanine phosphoribosyltransferase                               
  JAK2                              O60674        Tyrosine-protein kinase JAK2                                                 
  MMP9                              P14780        67 kDa matrix metalloproteinase-9                                            
  REG1A                             P05451        Lithostathine-1-alpha                                                        
  VDR                               P11473        Vitamin D3 receptor                                                          
  Isovitexin                        162350        31.29                                            0.72   APRT    P07741       Adenine phosphoribosyltransferase
  BIRC7                             Q96CA5        Baculoviral IAP repeat-containing protein 7                                  
  F2                                P00734        Prothrombin                                                                  
  GBA                               P04062        Beta-glucocerebrosidase                                                      
  HPRT1                             P00492        Hypoxanthine-guanine phosphoribosyltransferase                               
  JAK2                              O60674        Tyrosine-protein kinase JAK2                                                 
  MMP9                              P14780        67 kDa matrix metalloproteinase-9                                            
  REG1A                             P05451        Lithostathine-1-alpha                                                        
  VDR                               P11473        Vitamin D3 receptor                                                          
  Linarin                           5317025       39.84                                            0.71   AGXT    P21549       Serine pyruvate aminotransferase
  APRT                              P07741        Adenine phosphoribosyltransferase                                            
  BIRC7                             Q96CA5        Baculoviral IAP repeat-containing protein 7                                  
  F2                                P00734        Prothrombin                                                                  
  GBA                               P04062        Beta-glucocerebrosidase                                                      
  JAK2                              O60674        Tyrosine-protein kinase JAK2                                                 
  MMP9                              P14780        67 kDa matrix metalloproteinase-9                                            
  REG1A                             P05451        Lithostathine-1-alpha                                                        
  Rhamno-citrin-3,4′-digluco-side   --            32.52                                            0.64   APRT    P07741       Adenine phosphoribosyltransferase
  BIRC7                             Q96CA5        Baculoviral IAP repeat-containing protein 7                                  
  F2                                P00734        Prothrombin                                                                  
  GBA                               P04062        Beta-glucocerebrosidase                                                      
  HPRT1                             P00492        Hypoxanthine-guanine phosphoribosyltransferase                               
  JAK2                              O60674        Tyrosine-protein kinase JAK2                                                 
  MMP9                              P14780        67 kDa matrix metalloproteinase-9                                            
  REG1A                             P05451        Lithostathine-1-alpha                                                        
  Liquiriti-genin                   114829        32.76                                            0.18   AGXT    P21549       Serine pyruvate aminotransferase
  BIRC7                             Q96CA5        Baculoviral IAP repeat-containing protein 7                                  
  F2                                P00734        Prothrombin                                                                  
  HPRT1                             P00492        Hypoxanthine-guanine phosphoribosyltransferase                               
  JAK2                              O60674        Tyrosine-protein kinase JAK2                                                 
  MMP9                              P14780        67 kDa matrix metalloproteinase-9                                            
  REG1A                             P05451        Lithostathine-1-alpha                                                        
  VDR                               P11473        Vitamin D3 receptor                                                          
  β-Sitosterol                      222284        36.91                                            0.75   BIRC7   Q96CA5       Baculoviral IAP repeat-containing protein 7
  F2                                P00734        Prothrombin                                                                  
  JAK2                              O60674        Tyrosine-protein kinase JAK2                                                 
  LCN2                              P80188        Neutrophil gelatinase-associated lipocalin                                   
  VDR                               P11473        Vitamin D3 receptor                                                          

OB -- oral bioavailability; DL -- drug-like index; CID -- compound identity number.

###### 

Molecular docking of targets for Christina Loosestrife.

  Number                           Target   PDB ID   Compound           Docking score
  -------------------------------- -------- -------- ------------------ ---------------
  1                                JAK2     3UGC     Endogenic ligand   5.180
  Luteolin                         6.361                                
  Epicatechin                      6.294                                
  Quercetin                        6.370                                
  Isorhamnetin                     NA                                   
  β-Sitosterol                     NA                                   
  Kaempferol                       6.357                                
  Acacetin                         4.620                                
  Linarin                          8.288                                
  Liquiritigenin                   6.330                                
  Isovitexin                       6.610                                
  Hesperetin                       4.655                                
  Chrysoeriol                      4.655                                
  Naringenin                       6.626                                
  Rhamnocitrin-3, 4′-diglucoside   8.245                                
  Eucommin A                       NA                                   
  Medioresinol                     6.853                                
  2                                BIRC7    2I3H     Endogenic ligand   4.490
  Luteolin                         6.730                                
  Epicatechin                      6.760                                
  Quercetin                        6.775                                
  Isorhamnetin                     NA                                   
  β-Sitosterol                     NA                                   
  Kaempferol                       6.736                                
  Acacetin                         3.139                                
  Linarin                          5.262                                
  Liquiritigenin                   6.633                                
  Isovitexin                       5.518                                
  Hesperetin                       3.377                                
  Chrysoeriol                      3.338                                
  Naringenin                       6.630                                
  Rhamnocitrin-3, 4′-diglucoside   5.254                                
  Eucommin A                       NA                                   
  Medioresinol                     5.511                                
  3                                F2       4UD9     Endogenic ligand   4.790
  Luteolin                         5.899                                
  Epicatechin                      NA                                   
  Quercetin                        NA                                   
  Isorhamnetin                     NA                                   
  β-Sitosterol                     NA                                   
  Kaempferol                       6.017                                
  Acacetin                         3.660                                
  Linarin                          6.120                                
  Liquiritigenin                   5.856                                
  Isovitexin                       6.064                                
  Hesperetin                       4.001                                
  Chrysoeriol                      4.031                                
  Naringenin                       5.936                                
  Rhamnocitrin-3, 4′-diglucoside   6.218                                
  Eucommin A                       NA                                   
  Medioresinol                     6.100                                
  4                                MMP9     6ESM     Endogenic ligand   4.640
  Luteolin                         6.788                                
  Epicatechin                      NA                                   
  Quercetin                        NA                                   
  Isorhamnetin                     4.453                                
  β-Sitosterol                     NA                                   
  Kaempferol                       6.683                                
  Acacetin                         4.116                                
  Linarin                          7.096                                
  Liquiritigenin                   6.981                                
  Isovitexin                       6.419                                
  Hesperetin                       4.166                                
  Chrysoeriol                      4.284                                
  Naringenin                       6.844                                
  Rhamnocitrin-3, 4′-diglucoside   7.102                                
  Eucommin A                       NA                                   
  Medioresinol                     6.385                                
  5                                VDR      3B0T     Endogenic ligand   8.500
  Luteolin                         NA                                   
  Epicatechin                      NA                                   
  Quercetin                        NA                                   
  Isorhamnetin                     NA                                   
  β-Sitosterol                     NA                                   
  Kaempferol                       6.052                                
  Acacetin                         4.700                                
  Linarin                          8.331                                
  Liquiritigenin                   6.152                                
  Isovitexin                       NA                                   
  Hesperetin                       4.748                                
  Chrysoeriol                      4.731                                
  Naringenin                       6.138                                
  Rhamnocitrin-3, 4′-diglucoside   8.347                                
  Eucommin A                       NA                                   
  Medioresinol                     7.421                                
  6                                GBA      2NT0     Endogenic ligand   5.180
  Luteolin                         5.762                                
  Epicatechin                      6.229                                
  Quercetin                        5.809                                
  Isorhamnetin                     3.542                                
  β-Sitosterol                     5.376                                
  Kaempferol                       5.577                                
  Acacetin                         3.147                                
  Linarin                          5.543                                
  Liquiritigenin                   5.400                                
  Isovitexin                       5.658                                
  Hesperetin                       3.331                                
  Chrysoeriol                      3.478                                
  Naringenin                       NA                                   
  Rhamnocitrin-3, 4′-diglucoside   NA                                   
  Eucommin A                       NA                                   
  Medioresinol                     NA                                   
  7                                APRT     4X45     Endogenic ligand   5.700
  Luteolin                         7.171                                
  Epicatechin                      7.095                                
  Quercetin                        7.135                                
  Isorhamnetin                     4.444                                
  β-Sitosterol                     7.528                                
  Kaempferol                       7.160                                
  Acacetin                         4.214                                
  Linarin                          6.232                                
  Liquiritigenin                   7.154                                
  Isovitexin                       6.220                                
  Hesperetin                       4.334                                
  Chrysoeriol                      4.323                                
  Naringenin                       NA                                   
  Rhamnocitrin-3, 4′-diglucoside   NA                                   
  Eucommin A                       NA                                   
  Medioresinol                     NA                                   
  8                                HPRT1    4RAO     Endogenic ligand   5.370
  Luteolin                         7.118                                
  Epicatechin                      7.092                                
  Quercetin                        7.038                                
  Isorhamnetin                     4.493                                
  β-Sitosterol                     7.625                                
  Kaempferol                       7.178                                
  Acacetin                         4.236                                
  Linarin                          6.630                                
  Liquiritigenin                   7.156                                
  Isovitexin                       6.391                                
  Hesperetin                       4.294                                
  Chrysoeriol                      4.311                                
  Naringenin                       NA                                   
  Rhamnocitrin-3, 4′-diglucoside   NA                                   
  Eucommin A                       NA                                   
  Medioresinol                     NA                                   
  9                                AGXT     5F9S     Endogenic ligand   5.220
  Luteolin                         6.161                                
  Epicatechin                      6.398                                
  Quercetin                        6.349                                
  Isorhamnetin                     5.428                                
  β-Sitosterol                     8.408                                
  Kaempferol                       6.329                                
  Acacetin                         5.736                                
  Linarin                          8.406                                
  Liquiritigenin                   6.207                                
  Isovitexin                       7.780                                
  Hesperetin                       5.741                                
  Chrysoeriol                      5.455                                
  Naringenin                       NA                                   
  Rhamnocitrin-3, 4′-diglucoside   NA                                   
  Eucommin A                       NA                                   
  Medioresinol                     NA                                   
  10                               LCN2     4MVK     Endogenic ligand   5.190
  Luteolin                         6.684                                
  Epicatechin                      6.732                                
  Quercetin                        6.668                                
  Isorhamnetin                     3.984                                
  β-Sitosterol                     6.616                                
  Kaempferol                       6.735                                
  Acacetin                         3.567                                
  Linarin                          5.553                                
  Liquiritigenin                   6.565                                
  Isovitexin                       5.435                                
  Hesperetin                       3.642                                
  Chrysoeriol                      3.643                                
  Naringenin                       NA                                   
  Rhamnocitrin-3, 4′-diglucoside   NA                                   
  Eucommin A                       NA                                   
  Medioresinol                     NA                                   

NA -- not available; PDB -- Protein Data Bank.

###### 

Important targets and ingredients with a high node degree for Christina Loosestrife.

  Ingredients    Degree   Targets                                                           Target   Degree   Ingredients
  -------------- -------- ----------------------------------------------------------------- -------- -------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Epicatechin    11       AGXT, APRT, BIRC7, F2, GBA, HPRT1, JAK2, LCN2, MMP9, REG1A, VDR   JAK2     16       Acacetin, Chrysoeriol, Epicatechin, Eucommin A, Hesperetin, Isorhamnetin, Isovitexin, Kaempferol, Linarin, Liquiritigenin, Luteolin, Medioresinol, Naringenin, Quercetin, Rhamnocitrin-3,4′-diglucoside, β-Sitosterol
  Hesperetin     11       AGXT, APRT, BIRC7, F2, GBA, HPRT1, JAK2, LCN2, MMP9, REG1A, VDR   MMP9     15       Acacetin, Chrysoeriol, Epicatechin, Eucommin A, Hesperetin, Isorhamnetin, Isovitexin, Kaempferol, Linarin, Liquiritigenin, Luteolin, Medioresinol, Naringenin, Quercetin, Rhamnocitrin-3,4′-diglucoside
  Luteolin       11       AGXT, APRT, BIRC7, F2, GBA, HPRT1, JAK2, LCN2, MMP9, REG1A, VDR   APRT     14       Acacetin, Chrysoeriol, Epicatechin, Eucommin A, Hesperetin, Isorhamnetin, Isovitexin, Kaempferol, Linarin, Luteolin, Medioresinol, Naringenin, Quercetin, Rhamnocitrin-3,4′-diglucoside
  Medioresinol   11       AGXT, APRT, BIRC7, F2, GBA, HPRT1, JAK2, LCN2, MMP9, REG1A, VDR   HPRT1    13       Acacetin, Chrysoeriol, Epicatechin, Hesperetin, Isorhamnetin, Isovitexin, Kaempferol, Luteolin, Liquiritigenin, Medioresinol, Naringenin, Quercetin, Rhamnocitrin-3,4′-diglucoside
  Naringenin     11       AGXT, APRT, BIRC7, F2, GBA, HPRT1, JAK2, LCN2, MMP9, REG1A, VDR   LCN2     9        Acacetin, Epicatechin, Eucommin A, Hesperetin, Luteolin, Medioresinol, Naringenin, Quercetin, β-Sitosterol
  Quercetin      11       AGXT, APRT, BIRC7, F2, GBA, HPRT1, JAK2, LCN2, MMP9, REG1A, VDR                     
  Chrysoeriol    10       AGXT, APRT, BIRC7, F2, GBA, HPRT1, JAK2, MMP9, REG1A, VDR                           
  Eucommin A     10       AGXT, APRT, BIRC7, F2, GBA, JAK2, LCN2, MMP9, REG1A, VDR                            
  Isorhamnetin   10       AGXT, APRT, BIRC7, F2, GBA, HPRT1, JAK2, MMP9, REG1A, VDR                           
  Kaempferol     10       AGXT, APRT, BIRC7, F2, GBA, HPRT1, JAK2, MMP9, REG1A, VDR                           
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